基本信息
浏览量:262
职业迁徙
个人简介
rof Fraser is a clinician scientist, innovator and disruptor. His scientific endeavours highlighted to him the potential of medical technologies in the heart and lung arena when developed symbiotically with world class clinicians, researchers, developers - with the patient at the centre of these innovations.
In his roles as the founder of the CCRG ( https://ccrg.org.au ) , Australia’s largest acute care multidisciplinary research group in Australia, Founder of medical device company De Motu Cordis Pty Ltd (. https://demotucordis.co/) , and as an intensive care medicine specialist, Prof Fraser has seen time and again how the best and brightest innovators in the areas of cardiovascular, respiratory and chronic disease continue to face a critical funding gap to transport their early to mid stage innovations through to manufacture and commercialisation. It is through this gap that opportunities fall - and potential game-changing technologies can be lost.
As a result, Prof Fraser has co-founded the Quantum Medical Innovation Fund, focussing on medical innovations that make a quantum difference to both to patient outcomes and investor returns. Quantum’s unique advantage is its productive global network of medical and innovation leaders, thereby de-risking the investment decision making around early and mid-stage med-tech assets, and subsequently applying a strategy of active management to drive positive target outcomes. It is his network that facilitated the birth of the COVID Consortium ( https://www.covid-critical.com) - a global Critical Care Community born across 55 countries and approx 400 hospitals to share data , create real time dashboards with IBM and work towards the use of AI in management of COVID 19.
Prof Fraser continues to push at the boundaries of medicine, science and technology, all in the pursuit of ensuring that critically ill patients across the world have every opportunity to thrive - not just survive.
In his roles as the founder of the CCRG ( https://ccrg.org.au ) , Australia’s largest acute care multidisciplinary research group in Australia, Founder of medical device company De Motu Cordis Pty Ltd (. https://demotucordis.co/) , and as an intensive care medicine specialist, Prof Fraser has seen time and again how the best and brightest innovators in the areas of cardiovascular, respiratory and chronic disease continue to face a critical funding gap to transport their early to mid stage innovations through to manufacture and commercialisation. It is through this gap that opportunities fall - and potential game-changing technologies can be lost.
As a result, Prof Fraser has co-founded the Quantum Medical Innovation Fund, focussing on medical innovations that make a quantum difference to both to patient outcomes and investor returns. Quantum’s unique advantage is its productive global network of medical and innovation leaders, thereby de-risking the investment decision making around early and mid-stage med-tech assets, and subsequently applying a strategy of active management to drive positive target outcomes. It is his network that facilitated the birth of the COVID Consortium ( https://www.covid-critical.com) - a global Critical Care Community born across 55 countries and approx 400 hospitals to share data , create real time dashboards with IBM and work towards the use of AI in management of COVID 19.
Prof Fraser continues to push at the boundaries of medicine, science and technology, all in the pursuit of ensuring that critically ill patients across the world have every opportunity to thrive - not just survive.
研究兴趣
论文共 831 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
EUROPEAN JOURNAL OF CLINICAL INVESTIGATIONno. 2 (2024)
Critical Careno. 1 (2024): 34-34
International journal of cardiology (2024): 131911-131911
Douglas E. Vincent,Nader Moazami, David D’Alessandro,John F. Fraser,Silver Heinsar,Ellen T. Roche, Brian C. Ayers, Manisha Singh, Nina Langer, Shriprasad R. Deshpande, R.D.B. Jaquiss,Kiyotaka Fukamachi,
JACC: Basic to Translational Scienceno. 4 (2024): 456-458
JOURNAL OF HEART AND LUNG TRANSPLANTATIONno. 3 (2024): 485-495
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICSno. 1 (2024): 184-191
Douglas E. Vincent,Nader Moazami, David D’Alessandro,John F. Fraser,Silver Heinsar,Ellen T. Roche,Brian C. Ayers,Manisha Singh, Nina Langer,Shriprasad R. Deshpande, R.D.B. Jaquiss,Kiyotaka Fukamachi,
JACC: Basic to Translational Scienceno. 4 (2024): 456-458
ANTIMICROBIAL AGENTS AND CHEMOTHERAPYno. 1 (2024): e0120123-e0120123
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn